Drugs / Tantum Verde
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT07186114 Comparator | Mar 2023 → Dec 2024 | mucositis | Cairo University | Completed | No outcome recorded |
| — | NCT07229469 Comparator | Dec 2023 → May 2025 | aphthous stomatitis | Ain Shams University | Completed | No outcome recorded |
| — | NCT02190162 Comparator | Jul 2014 → Dec 2017 | adenoid hypertrophy, tonsillitis | Western Galilee Hospital-Nahariya | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tantum Verde | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07186114 ↗ |
| Known as | Benzydamine Hydrochloride | “Benzydamine Hydrochloride (Tantum Verde) mouthwash three times a day for two weeks.” NCT07186114 ↗ |
| Route | Oral | “Tantum Verde mouth rinse” NCT07229469 ↗ |